RESUMO
In collaboration with the American College of Veterinary Pathologists.
Assuntos
Patologia Veterinária , Médicos Veterinários , Animais , Humanos , Estados UnidosRESUMO
OBJECTIVE: To characterize the biochemical, functional, and histopathologic changes associated with lomustine-induced liver injury in dogs. ANIMALS: I0 healthy purpose-bred sexually intact female hounds. PROCEDURES: Dogs were randomly assigned to receive lomustine (approx 75 mg/m2, PO, q 21 d for 5 doses) alone (n = 5) or with prednisone (approx 1.5 mg/kg, PO, q 24 h for 12 weeks; 5). For each dog, a CBC, serum biochemical analysis, liver function testing, urinalysis, and ultrasonographic examination of the liver with acquisition of liver biopsy specimens were performed before and at predetermined times during and after lomustine administration. Results were compared between dogs that did and did not receive prednisone. RESULTS: 7 of the I0 dogs developed clinical signs of liver failure. For all dogs, serum alanine aminotransferase (ALT) and alkaline phosphatase (ALP) activities, bile acid concentrations, and liver histologic score increased and hepatic reduced glutathione content decreased over time. Peak serum ALT (r = 0.79) and ALP (r = 0.90) activities and bile acid concentration (r = 0.68) were positively correlated with the final histologic score. Prednisone did not appear to have a protective effect on histologic score. CONCLUSIONS AND CLINICAL RELEVANCE: In dogs, liver enzyme activities, particularly ALT and ALP activities, should be closely monitored during lomustine treatment and acute increases in those activities may warrant discontinuation of lomustine to mitigate liver injury. Nonspecific ultrasonographic findings and abnormal increases in liver function tests were not detected until the onset of clinical liver failure. Glutathione depletion may have a role in lomustine-induced hepatopathy and warrants further investigation.
Assuntos
Doença Hepática Crônica Induzida por Substâncias e Drogas/veterinária , Doenças do Cão/induzido quimicamente , Doenças do Cão/tratamento farmacológico , Lomustina , Alanina Transaminase , Fosfatase Alcalina , Animais , Cães , Feminino , Fígado , Lomustina/efeitos adversosRESUMO
BACKGROUND: Cutaneous histiocytomas (CH) are derived from epidermal Langerhans cells. Single CH are generally associated with a good prognosis in dogs because most undergo spontaneous remission. However, aggressive behaviour and lymph node metastasis have been reported in a small number of dogs with single CH. OBJECTIVE: To describe the clinical presentation, treatment and disease progression of an aggressive CH located in the ear canal of a dog. ANIMAL: An 8-year-old intact male Rottweiler dog. METHODS AND MATERIALS: A unilateral ear canal mass was identified as a CH on routine haematoxylin and eosin stained samples. The diagnosis was confirmed by the demonstration of markers associated with Langerhans cells (Iba-1, E-cadherin and CD18) and the absence of markers associated with B cells (CD79a, CD20, Pax5), T cells (CD3), plasma cells (Mum-1) and macrophages (CD11d, CD204). RESULTS: A total ear canal ablation was performed, but tumour cells extended throughout the horizontal canal and to the deep surgical margin. Due to the locally invasive nature of the mass and incomplete excision, adjunctive chemotherapy with CCNU was pursued. No measurable local disease was appreciable at the time of the last treatment. At 250 days post-surgery the dog was euthanized owing to the development of multiple abdominal masses. No evidence of local tumour recurrence was noted. CONCLUSIONS AND CLINICAL IMPORTANCE: Although single CH are typically associated with benign behaviour, the mass in this dog demonstrated locally invasive behaviour. Cutaneous histiocytomas in the ear canals of dogs may represent a particularly aggressive variant of the condition.
Assuntos
Doenças do Cão/diagnóstico , Meato Acústico Externo/patologia , Neoplasias da Orelha/veterinária , Histiocitoma/veterinária , Pele/patologia , Tomografia Computadorizada por Raios X/veterinária , Animais , Progressão da Doença , Cães , Neoplasias da Orelha/diagnóstico por imagem , Neoplasias da Orelha/patologia , Eutanásia Animal , Cabeça/diagnóstico por imagem , Histiocitoma/diagnóstico por imagem , Histiocitoma/patologia , Masculino , Metástase NeoplásicaRESUMO
A 10-year-old male captive tiger (Panthera tigris) developed right-sided facial asymmetry and enlargement. Computed tomography revealed a destructive mass of the right maxillary bone with right nasal cavity involvement. Histopathology indicated a spindle cell sarcoma. A single fraction of 22 Gy using stereotactic radiotherapy was prescribed. After treatment, the facial conformation returned to normal and the tiger resumed normal behavior. Diagnostics 4 months later indicated severe metastatic disease. Humane euthanasia and necropsy were performed. This is the first case utilizing stereotactic radiotherapy for the treatment of cancer in a tiger.
Assuntos
Neoplasias Ósseas/veterinária , Leiomiossarcoma/veterinária , Neoplasias Maxilares/veterinária , Radiocirurgia/veterinária , Tigres , Animais , Neoplasias Ósseas/diagnóstico , Neoplasias Ósseas/radioterapia , Leiomiossarcoma/diagnóstico por imagem , Leiomiossarcoma/radioterapia , Masculino , Neoplasias Maxilares/diagnóstico por imagem , Neoplasias Maxilares/radioterapia , Tomografia Computadorizada por Raios X/veterinária , Resultado do TratamentoRESUMO
An 11-year-old, spayed female, domestic shorthair cat was presented with a non-resectable abdominal mass diagnosed as carcinomatosis of pancreatic origin. Treatment with toceranib phosphate was started. Abdominal ultrasound approximately 1 year after diagnosis revealed progressive disease. The cat was humanely euthanized approximately 792 days after initial presentation due to progressive clinical signs.
Contrôle clinique à long terme du carcinome pancréatique félin avec le tocéranib phosphate. Un chatte commune domestique stérilisée âgée de 11 ans a été présentée avec une masse abdominale non résécable diagnostiquée comme une carcinomatose d'origine pancréatique. Le tocéranib phosphate a été administré. L'échographie abdominale environ 1 an après le diagnostic a révélé une maladie progressive. La chatte a été euthanasiée sans cruauté environ 792 jours après la présentation initiale en raison de signes cliniques progressifs.(Traduit par Isabelle Vallières).
Assuntos
Antineoplásicos/uso terapêutico , Doenças do Gato/tratamento farmacológico , Indóis/uso terapêutico , Neoplasias Pancreáticas/veterinária , Pirróis/uso terapêutico , Animais , Carcinoma/tratamento farmacológico , Carcinoma/veterinária , Gatos , Feminino , Neoplasias Pancreáticas/diagnóstico por imagem , Neoplasias Pancreáticas/tratamento farmacológico , Neoplasias PancreáticasAssuntos
Adenocarcinoma Folicular/veterinária , Doenças do Cão/diagnóstico , Neoplasias da Glândula Tireoide/veterinária , Adenocarcinoma Folicular/complicações , Adenocarcinoma Folicular/diagnóstico , Animais , Biópsia por Agulha Fina/veterinária , Doenças do Cão/diagnóstico por imagem , Doenças do Cão/patologia , Cães , Masculino , Cisto Tireoglosso/complicações , Cisto Tireoglosso/diagnóstico , Cisto Tireoglosso/veterinária , Neoplasias da Glândula Tireoide/complicações , Neoplasias da Glândula Tireoide/diagnóstico , Tomografia Computadorizada por Raios X/veterináriaRESUMO
OBJECTIVE To compare percentages of mast cells in lymph node (LN) aspirate samples from clinically normal dogs, dogs with allergic dermatologic disease (ADD), and dogs with cutaneous mast cell tumors (MCTs). DESIGN Prospective cross-sectional study. ANIMALS 20 healthy dogs (group 1), 20 dogs with ADD (group 2), and 20 dogs with an MCT on the head or limbs (group 3). PROCEDURES LN aspirate samples were obtained from easily accessible LNs in group 1, affected skin regions in group 2, and the likely draining LN or LNs of the MCT in group 3; the percentage of mast cells was manually determined for each LN. For group 3, LNs were cytologically categorized with a modified version of a published metastasis categorization scheme. RESULTS Median (range) percentage of mast cells in aspirate samples was 0% (0% to 0.1%) for group 1, 0.05% (0% to 0.55%) for group 2, and 0.4% (0% to 77.4%) for group 3. In group 3, 16 LNs (13 dogs) were palpably normal in size; 6 of these had evidence of possible or certain metastasis. Seven LNs (7 dogs) in group 3 were palpably enlarged, and 5 of these had evidence of certain metastasis. CONCLUSIONS AND CLINICAL RELEVANCE This study provided evidence to support the use of a uniform cytologic grading system to further define nodal metastasis in dogs with MCTs as well as estimates of the percentage of mast cells in LN aspirate samples for healthy dogs and dogs with ADD. Palpably normal LNs in dogs with cutaneous MCT may contain metastasis.
Assuntos
Dermatite/veterinária , Doenças do Cão/patologia , Linfonodos/citologia , Mastócitos/citologia , Mastocitoma/veterinária , Neoplasias Cutâneas/veterinária , Animais , Estudos Transversais , Dermatite/patologia , Cães , Feminino , Masculino , Mastocitoma/patologia , Estudos Prospectivos , Neoplasias Cutâneas/patologiaRESUMO
An 8-year-old castrated male mixed breed dog was presented for a squamous cell carcinoma of the left frontal sinus. A partial craniectomy was performed and polytetrafluoroethylene mesh was placed over the craniectomy site. The dog recovered well with a good cosmetic outcome. Histopathology confirmed primary frontal sinus squamous cell carcinoma.
Carcinome squameux primaire du sinus frontal chez un chien traité par excision chirurgicale. Un chien castré de race croisée âgé de 8 ans a été présenté pour un carcinome squameux du sinus frontal gauche. Une craniectomie partielle a été réalisée et un tamis de polytétrafluoroéthylène a été placé sur le site de la craniectomie. Le chien s'est rétabli avec un bon résultat esthétique. L'histopathologie a confirmé un carcinome squameux primaire du sinus frontal.(Traduit par Isabelle Vallières).